Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate (full – 2008)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659532/

Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full – 2011)http://onlinelibrary.wiley.com/doi/1...1.01444.x/full

Expression and function of monoacylglycerol lipase in mouse β-cells and human islets of Langerhans (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22739267

Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24148808